Biocure Technology Adopts Semi-Annual Financial Reporting

Vancouver, B.C. — May 8, 2026 — Leads & Copy —

Biocure Technology Inc. (CSE: CURE) (OTCQB: BICTF) has announced it will adopt semi-annual financial reporting, according to a press release issued May 8, 2026.

The decision aligns with Coordinated Blanket Order 51 – 933, which provides exemptions for certain venture issuers.

The order permits eligible venture issuers to transition from quarterly to semi-annual financial reporting. Biocure, whose fiscal year concludes on December 31, meets the criteria outlined in CBO 51-933. These include being a venture issuer with annual revenues below $10 million and maintaining a clean 12-month continuous disclosure record.

As a result, Biocure will not be filing interim financial statements and associated management’s discussion and analysis for the three-month period ending March 31, 2026.

The company will continue to file audited annual financial statements within 120 days of December 31 and six-month interim financial reports within 60 days of June 30. Biocure affirmed its commitment to timely disclosure, pledging to report all material changes and significant developments as required under National Instrument 51-102.

Biocure Technology Inc. is a Canadian mineral exploration company focused on acquiring, exploring, and developing mineral properties. The company is focused on advancing its exploration projects and evaluating additional resource opportunities.

Yee Sing (Simon) Cheng, CEO, made the announcement on behalf of Biocure Technology Inc.

This news release is being filed pursuant to Coordinated Blanket Order 51-933 Exemptions to Permit Semi-Annual Reporting for Certain Venture Issuers.

Source: Biocure Technology Inc.